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19-Nor-10-azasteroids are a new class of 5R-reductase inhibitors whose activity depends on
the presence of the bridgehead N-10 atom conjugated with the 4-en-3-one moiety in the A ring.
The X-ray structure of 19-nor-10-azasteroid 1 has been determined and it is compared with
the X-ray structure of testosterone. A complete conformational analysis of these compounds
has been performed, determining the number and energy of the possible conformers, as well
as the molecular flexibility of the 10-azasteroidal skeleton. Thus, MM2* molecular mechanics
calculations and AM1 semiempirical energy refinements revealed that 19-nor-10-azasteroids
1-3 have four possible conformations with very small energy differences and that they are
very flexible molecules. The conformational analysis has been extended to testosterone (4),
which also showed conformational flexibility, with three different conformations, and to
6-azasteroid 5 and 4-azasteroid 6, for which only two thermally accessible conformations have
been found. Compared to 19-nor-10-azasteroids 1-3, azasteroids 5 and 6 appear to be more
rigid structures. By a best fit analysis of all conformers of 1-5 with the global minimum of
testosterone (4-I) it has been found that the lowest energy conformers of 1, 3, and 5 are very
close to the structure of 4-I, and among the conformers of 2, the best similarity has been
observed for the highest energy conformer 2-IV.
Introduction
The reduction of testosterone (T) to dihydrotestoster-
one (DHT) in several human tissues is catalyzed by two
NADPH-dependent isoenzymes of steroid 5R-reductase
(5RR), named type 1 and type 2 (5RR-1 and 5RR-2).2 The
blockade of the formation of DHT by using selective
inhibitors of 5RR has recently made possible a new
therapeutic approach to the pharmacological treatment
of prevalent human diseases such as benign prostatic
hyperplasia (BPH), acne, male pattern baldness, and
alopecia.3 Therefore significant research has been car-
ried out to find new potent and selective inhibitors of
5RR-1 and -2.4
Recently, we have described the synthesis and bio-
logical evaluation of a series of 19-nor-10-azasteroids,
a new class of inhibitors for the human steroid-5R-
reductases.1 The inhibitory potency of these com-
pounds, toward 5RR-1 and 5RR-2, was governed by the
presence and position of a double bond in the C ring, as
well as by the type of substituent at the 17 position.
Moreover, the presence in their skeleton of the bridge-
head nitrogen atom at position 10, conjugated with the
3-oxo group through the C-4, C-5 double bond, was an
essential feature to maintain the inhibitory activity, and
in fact, the 19-nor-10-azasteroids lacking in the C-4dC-5
bond were inactive toward the enzyme. Ab initio
calculations on tricyclic models1 indicated that this
particular arrangement of atoms could increase the
nucleophilic character of the carbonyl group with respect
to testosterone, thus causing a stronger interaction with
the electrophilic residues present in the 5RR active
site.1,4 However, this electronic effect alone did not
explain the difference in the inhibitory potency observed
for the ¢9(11) and ¢8(9) regioisomers of the most active
compounds, for instance, those having a 17â-N-tert-
butylcarbamoyl substituent, or the decrease of activity
when the double bond in the C ring was absent.1
A conformational study on the novel 19-nor-10-aza-
steroid inhibitors should be the first step in the search
of a rationale for the inhibition potency changes men-
tioned above. Therefore, in this paper we report on the
X-ray structure determination of azasteroid 1 and on a
molecular modeling studysperformed on compounds
1-3 (Figure 1)sboth aimed at defining the conforma-
tional changes, in the steroidal skeleton, determined by
the presence of the bridgehead N-10 atom conjugated
with two double bonds in the A and C rings (compounds
1 and 2) or with a single double bond in the A ring
(compound 3). As a reference steroidal structure, we
have chosen testosterone (4), the natural substrate of
5R-reductase, and thus, the same molecular modeling
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approach used for compounds 1-3 has been extended
to 4. The modeling has consisted of the MM2* energy
minimization5 of each compound, followed by a complete
Monte Carlo conformational search, and a final AM1
geometry optimization of the conformers found.
Then, in order to evaluate the backbone conforma-
tional differences between 19-nor-10-azasteroids 1-3
and other classes of azasteroidal inhibitors, for instance
6- and 4-azasteroids, the same analysis has been applied
to compounds 56 and 67 (Figure 1).
The X-ray structure of 1 and the results of the
conformational analysis on compounds 1-6 are dis-
cussed and, finally, the possible bioactive conformations
of 19-nor-10-azasteroids are proposed.
Results and Discussion
Synthesis of 19-Nor-10-azasteroids. The strategy
used for the synthesis of 19-nor-10-azasteroids always
produced these compounds as mixtures of two different
isomers having a double bond at the 9(11) or 8(9)
position (Scheme 1).1,8 Usually the 9(11) isomer pre-
dominated over the 8(9) isomer, resulting from kinetic
control of the reaction. Moreover, the major isomer was
also the thermodynamically favored one, since it was
predominant after equilibration of the mixtures under
basic catalysis. Owing to this equilibration, it was very
difficult to obtain a pure single isomer and only in the
case of compound 1 this was possible. Thus, the 10:1
reaction mixture of compounds 1 and 2, after two
crystallizations from ethyl acetate, provided pure com-
pound 1, which, dissolved again in the same solvent,
gave crystals suitable for X-ray determination after slow
concentration. Compound 1 was also used as a starting
material for the synthesis of azasteroid 3.1
Structure Description and Comparison. The
description of the steroid conformers is made according
to the method reported by Bucourt et al. in their study
on the A/B ring fusion of testosterone.9 With this
method, the sign and value of torsion angles are
reported inside the cycles, and a quasi-trans and quasi-
cis fusion of A and B rings is defined on the basis of the
discordance or concordance of the torsional angle signs
around the fusion bond (Figure 2).
Furthermore, because the natural substrates of the
enzyme 5R-reductase are 4-en-3-one steroids, we exam-
ine the differences in the distorsion of the A ring
between the conformers of one substrate (testosterone)
and the 10-, 4-, and 6-azasteroid inhibitors with the
same approach as Duax et al.10 They used the distance
of C-2 from the C-3, C-4, C-5, and C-10 mean plane as
a sensitive measure of the A ring conformation: C-2 is
above this plane (positive value of the distance) when
the A ring has the 1R-2â or 2â-sofa conformation, in
the plane (distance very close to 0 Å) when the A ring
has the 1R-sofa or 1â-sofa conformation, and below
the plane (negative value of the distance) when the A
ring has 1â-2R or 2R-sofa conformation (Figure 3).
Duax et al. observed that in most of the crystal-
lographic structures of natural steroids having the 4-en-
3-one moiety, the A ring has a conformation ranging
from the ideal 1R-2â half chair to the ideal 1R-sofa.10
In these “normal” conformations the C-1 atom is in R
position with respect to the plane. However, the same
authors pointed out that “inverted” conformations (i.e.
with the C-1 in â position) are often observed in
Figure 1.
Figure 2. Quasi-cis and quasi-trans A/B ring fusions of
steroids.
Figure 3. A ring type of steroids defined by the distances of
C-1 and C-2 from the C-3, C-4, C-5, and C-10 mean plane.
Scheme 1
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crystallographic structures of semisynthetic steroids, in
particular those having additional double bonds in the
B or C ring or a 19-nor backbone. Since 19-nor-10-
azasteroids have all these features, we have considered
useful the application of the same conformational
description reported in Figure 3, that is, the distances
of C-1 and C-2 from the C-3, C-4, C-5, and N-10 plane,
as well as the extension of this approach to the B ring
description by considering the sign and value of the
distances of C-6 and C-7 from the same mean plane.
X-ray Structure of ¢9(11)-19-Nor-10-azasteroid 1.
The crystallographic structure (1-X-ray) of ¢9(11)-19-nor-
10-azaandrostenedione (1) is reported in Figure 4, and
a formula with signs and values of the torsional angles
is in Figure 6.
A quasi-trans configuration of the A/B and B/C ring
fusions is present in 1-X-ray structure. Other selected
structural data are reported in Tables 1 and 3 (entry
1). The most important feature of the crystallographic
structure is the presence of a conjugated system ex-
tended from O-3 to C-11. Since the N-10 atom is
directly connected to the O-3dC-3sC-4dC-5 enone
system and to the C-9dC-11 bond, its lone pair should
be shared by these two systems. In fact, a strong
conjugation of the nitrogen atom is evident, considering
the distance of N-10 (in â position) from the C-1, C-5,
and C-9 plane, which is only 0.104(2) Å (Table 3, entry
1), and the sum of the bond angles around N-10, which
is very close to 360° (358.4°); these values are consistent
with the sp2 hybridization of the N-10 atom. However,
Figure 4. Stereoplot of the crystal structure of 1.
Table 1. Selected Conformational Data of the Crystallographic Structure of 1 (1-X-ray) and the Predicted Conformers of
10-Azasteroids 1-3
distance from C-3, C-4, C-5, N-10 plane (Å)c
entry
struc-
ture
A/B
ring
fusion
A ring
type
B ring
type
Hfa
(kcal/
mol)
¢E
(kcal/
mol)
rms (Å)
with
X-ray
torsion (deg)b
O-3dC-3sC-4dC-5 C-1 C-2 C-6 C-7
¢9(11)-19-Nor-10-azasteroid 1
1 1-X-ray q.-trans 1R-2â 6â-7R - - - -177.8(4) (1.87) -0.319 (4) 0.291 (4) 0.224 (3) -0.208 (3)
2 1-I q.-trans 1R-2â 6â-7R -53.855 0 0.119 169.66 (10.34) -0.20 0.33 0.11 -0.47
3 1-II q.-trans 2R-sofa 7R-sofa -52.930 0.925 0.298 -165.32 (14.68) 0.03 -0.44 0.05 -0.36
4 1-III q.-trans 1R-2â 7â-sofa -52.182 1.673 0.291 174.64 (5.36) -0.39 0.15 0.01 0.89
5 1-IV q.-trans 1â-2R 7â-sofa -51.160 2.695 0.328 -172.36 (7.64) 0.30 -0.23 0.06 0.99
¢8(9)-19-Nor-10-azasteroid 2
6 2-I q.-trans 1â-2R 7â-sofa -53.406 0 -169.55 (10.45) 0.22 -0.31 0.09 0.74
7 2-II q.-trans 1â-2R 7R-sofa -53.344 0.062 -172.14 (7.86) 0.25 -0.28 0.04 -0.60
8 2-III q.-trans 1R-2â 7â-sofa -53.320 0.086 172.27 (7.73) -0.29 0.25 -0.01 0.60
9 2-IV q.-trans 1R-2â 7R-sofa -53.307 0.099 169.89 (10.11) -0.23 0.30 0.08 -0.77
19-Nor-10-azasteroid 3
10 3-I q.-trans 1R-2â 6â-7R -74.280 - 170.00 (10.00) -0.25 0.28 0.11 -0.58
11 3-II q.-trans 1â-2R 7R-sofa -73.471 0.809 -169.21 (10.79) 0.15 -0.36 0.06 -0.26
12 3-III q.-trans 1â-2R 7â-sofa -73.113 1.167 -173.38 (6.62) 0.38 -0.15 -0.03 1.12
13 3-IV q.-trans 1R-2â 7â-sofa -72.230 2.050 -173.64 (6.36) -0.36 0.15 -0.05 0.78
a Calculated on AM1 energy-minimized structures through Spartan software. b The deviation from planarity (180°) is reported in brackets.
c This is a mean plane.
Table 2. Selected Conformational Data of the Crystallographic Structure of Testosterone (4) and the Predicted Conformers of 4-6
distance from C-3, X-4, C-5, C-10 plane (Å)c,d
entry
struc-
ture
A/B
ring
fusion
A ring
type
B ring
type
Hfa
(kcal/
mol)
¢E
(kcal/
mol)
rms (Å)
with
X-ray
torsion (deg)b
O-3dC-3-X-4dC-5d C-1 C-2 Y-6d C-7
Testosterone (4)
1 4-X-ray q.-trans 1R-2â 6â-7R - - - -179.29 (0.71) -0.49 0.16 0.19 -0.84
2 4-I q.-trans 1R-2â 7R-sofae -115.584 0 0.098 172.38 (7.62) -0.42 0.24 0.09 -0.93
3 4-II q.-cis 1â-2R 6R-7R -113.215 2.369 0.384 -167.49 (12.51) 0.26 -0.43 -0.21 -1.54
4 4-III q.-trans 1R-2R 6R-7â -112.14 3.444 0.304 -174.10 (5.9) -0.72 -0.19 -0.14 0.43
6-Azasteroid 5
5 5-I q.-trans 1R-sofa 6â-7R -96.790 0 179.77 (0.23) -0.61 0.02 0.12 -0.57
6 5-II q.-trans 2R-sofa 7R-sofa -91.482 5.31 -159.37 (20.63) 0.07 -0.58 0.08 -0.90
4-Azasteroid 6
7 6-I q.-trans 1R-2R 6â-sofa -119.022 0 168.76 (11.24) -0.77 -0.36 0.61 0.09
8 6-II q.-trans 1R-2R 6â-7R -118.025 0.997 -172.61 (7.39) -0.65 -1.05 0.38 -0.21
a Calculated on AM1 energy-minimized structures through Spartan software. b The deviation from planarity (180°) is reported in brackets.
c This is a mean plane. d X ) Y ) C for compound 4; X ) C, Y ) N for compound 5; X ) N, Y ) C for compound 6. e The 6â-7R conformation
should be more appropriate (see text).
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a certain deviation from a complete planarity of the
O-3dC-3sC-4dC-5sN-10sC-9dC-11 system exists, as
revealed by the angular values of the torsions C-4dC-
5sN-10sC-9 [-172.6(3)°] and C-11dC-9sN-10sC-5
[158.6(3)°] lower than 180° (Table 3, entry 1). Moreover,
the smaller deviation from planarity of the first torsion
angle (7° compared to 21° of the latter one) and the
minor length of the C-5sN-10 bond [1.367(4) Å] with
respect to the N-10sC-9 bond [1.417(4) Å] are consistent
with a greater conjugation of the N-10 atom with the
C-4dC-5 bond than with the C-9dC-11 bond.
Finally, according to the notation of Duax et al.10 the
A ring in 1-X-ray is in a “normal” 1R-2â conformation,
being that the distances of C-1 and C-2 from the C-3,
C-4, C-5, and N-10 mean plane are -0.319(4) and 0.291-
(4) Å, respectively.
In Figure 5 the deviation of C-2 from this plane is
plotted versus the torsion angle O-3dC-3sC-4dC-5,
which measures the conjugation of the enone system.
Using this type of analysis, on the basis of a system-
atic study of the A ring conformation of 119 crystal-
lographic structures of 4-en-3-one steroids, Duax et al.10
observed that the “normal” conformations are charac-
teristic of 4-en-3-one and 4,9,11-trien-3-one structures,
whereas 4,9-dien-3-ones have inverted conformations.
Despite ¢9(11)-19-nor-10-azasteroid 1 having only one
double bond in the C-ring, it presents a “normal” 1R-
2â conformation and thus appears more similar to a 4,9,-
11-trien- or 4-en-3-one than a 4,9-dien-3-one steroid.
However, being as azasteroid 1 is a competitive inhibitor
versus testosterone, a comparison of 1-X-ray with an
X-ray structure of testosterone should be more relevant.
Depending on the crystallization solvent, different
conformations in independent crystals of testosterone
have been found.9,11-14 A comparative analysis between
the conformations of testosterone obtained by molecular
mechanics calculations and crystallographic data has
been made by Bucourt et al.,9 who pointed out that the
highest distorsions in the A ring are associated with the
structures presenting the strongest hydrogen bond
between the O-3 atom and a molecule of the crystal-
lization solvent or another molecule of testosterone.
Among the reported crystal structures of testosterone
we have chosen for comparison that of the orthorhombic
form of hydrated testosterone (P212121)11 (4-X-ray)
which, having a weaker hydrogen bond, has a minor
distorsion in the A ring.9
The internal torsion angles of 4-X-ray structure are
reported in Figure 6, and some selected structural
parameters are reported in Table 2 (entry 1). Looking
at the conformation of the A and B rings, the X-ray
structure of ¢9(11)-19-nor-10-azasteroid (1-X-ray, Table
1, entry 1) shows a considerable similarity to that of
testosterone (4-X-ray, Table 2, entry 1). In fact both
structures have the A ring in the 1R-2â conformation
and the B ring in the 6â-7R one, with a quasi-trans
A/B ring fusion. Moreover 1-X-ray and 4-X-ray struc-
tures have very close O-3dC-3sC-4dC-5 torsion angle
values [-177.8(4)° for 1-X-ray and -179.29° for 4-X-ray],
as well as quite similar distances of C-2 from the C-3,
C-4, C-5, and C- or N-10 plane (0.291 and 0.16 Å for
1-X-ray and 4-X-ray, respectively). Consequently, the
two crystallographic structures occupy very close posi-
tions in the plot reported in Figure 5.
Conformational Analysis of ¢9(11)-19-Nor-10-aza-
steroid 1. It is known that the X-ray-derived structure
of steroids corresponds in many cases to the global
minimum energy conformation or local minimum energy
conformations that are less than 2 kcal/mol above the
global minimum.15-17 However, it has been recently
pointed out that the flexibility of the skeleton may be
an important property of the steroids for best fit to
receptors.18 The absence of the C-19 methyl group has
Table 3. Selected Conformational Data of the Crystallographic Structure of 1 and the Predicted Conformers of 1 and 2
¢9(11)-19-Nor-10-azasteroid 1
entry structure
torsion (deg)a
C-4dC-5sN-10sC-9
torsion (deg)a
C-11dC-9sN-10sC-5
distance and position of N-10 from
the C-1, C-5, and C-9 plane (Å)
1 1-X-ray -172.6[3] (7.4) 158.6[3] (21.4) 0.104[2] (â)
2 1-I -168.36 (11.64) 158.14 (21.86) 0.139 (â)
3 1-II 164.67 (15.33) -175.87 (4.13) 0.109 (R)
4 1-III -172.38 (7.62) 134.84 (45.16) 0.193 (â)
5 1-IV 172.31 (7.69) 145.83 (34.17) 0.156 (R)
¢8(9)-19-Nor-10-azasteroid 2
entry structure
torsion (deg)a
C-4dC-5sN-10sC-9
torsion (deg)b
C-8dC-9sN-10sC-5
distance and position of N-10 from
the C-1, C-5, and C-9 plane (Å)
6 2-I 165.97 (14.03) -1.39 (1.39) 0.170 (R)
7 2-II 175.30 (4.70) 19.06 (19.06) 0.121 (R)
8 2-III -174.13 (5.87) -19.38 (19.38) 0.134 (â)
9 2-IV -165.74 (14.26) 1.9 (1.9) 0.179 (â)
a The deviation from planarity (180°) is reported in brackets. b The deviation from planarity (0°) is reported in brackets.
Figure 5. Distance of C-2 from the C-3, C- or N-4, C-5, and
C- or N-10 mean plane in the predicted conformers of com-
pounds 1 (0), 2 (O), 3 (*), 4 (4), 5 (3), and 6 (]), and in 4-X-
ray (+) and 1-X-ray ().
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been related to an increase of flexibility of estrogen18
or 19-norandrogen derivatives as compared to the
normal androgens.9,19 In fact, both 19-nortestosterone
and estradiol or estrone can assume different conforma-
tions in different crystalline modifications or also in the
same crystal. The conformational flexibility of the
steroids could also be increased by the presence of
endocyclic double bonds which lowers the energy of the
transition barriers between different conformers.20
Since the most distinctive features of 19-nor-10-
azasteroid 1 are the absence of the C-19 methyl group
and the presence of two endocyclic C-C double bonds,
we have considered the possibility that this compound
could have other minimum energy conformations dif-
ferent from that observed in the crystal. Thus a
systematic conformational search has been performed,
starting from the crystallographic structure, in order
to determine the number and the energy of all possible
conformers as well as the energy of the transition
barriers between them.
The X-ray structure of 19-nor-10-azasteroid 1 was
introduced in MacroModel and energy minimized using
the MM2* force field, and then an exhaustive confor-
mational analysis was carried out by a Monte Carlo
method. This consisted of the systematic breaking and
then in the casual recomposition of some selected bonds
followed by the minimization process. In particular,
three bonds (C-1sC-2, C-6sC-7, and C-11sC-12) of the
A, B and C rings were selected and 1000 cycles of
conformational analysis were made, generating 1000
structures, each of them minimized until the conver-
gence criterium was reached. These conformations were
compared and resulted in nine different conformers.
Three conformers having an energy higher than 40 kcal/
mol above the global minimum energy were discarded
and the remaining six conformers were imported into
Spartan and optimized by AM1 semiempirical calcula-
tion. Two pairs of the MM2* minimized conformers
converged to the same geometry, so that the AM1
calculation produced only four different conformers
(named 1-I-IV, entries 2-5 of Tables 1 and 3) having
relative energies comprised in a range of only 2.7 kcal/
mol with respect to the global minimum.
Comparing the lowest energy conformer 1-I to 1-X-
ray (Table 1, entries 1 and 2), it is evident that 1-I
closely reproduces the crystallographic structure: the
root mean square (rms) fitting on all C and O atoms is
0.119 Å and 1-I has normal 1R-2â A ring and 6â-7R B
ring types, with a distance of C-2 from the C-3, C-4, C-5
and N-10 plane very close to the corresponding distance
in 1-X-ray. In the other conformers (entries 3-5),
energy and rms fitting with 1-X-ray increase with the
distortion of the A and B rings, reaching the highest
values in conformers 1-IV (entry 5) which has inverted
1â-2R A ring type and a 7â-sofa B ring. All predicted
conformers have a quasi-trans A/B ring fusion.
In Figure 6 the internal torsion angles of the global
minimum energy conformation 1-I are reported. The
angle values of 1-I are in accord with those of 1-X-ray,
with the exception of the torsions related to the 4-en-
3-one moiety. In correspondence to this observation, in
conformer 1-I the O-3dC-3sC-4dC-5 dihedral angle,
taken as a measure of the 4-en-3-one system conjuga-
tion, deviates to some extent (10.34°) from planarity
Figure 6. Internal torsion angles of some selected conformations of compounds 1-6 and of the X-ray structures of 1 and 4.
3470 Journal of Medicinal Chemistry, 1997, Vol. 40, No. 21 Guarna et al.
(Table 1, entry 1). Similar deviations, ranging from
5.36° to 14.68°, are observed for all the other predicted
conformers 1-II-IV (entries 3-5) and, as will be shown
later, they occur for all the minimized structures of the
other 10-azasteroids and testosterone.
Concerning the C-4dC-5sN-10sC-9dC-11 conju-
gated moiety, also in this case greater deviations from
planarity than in 1-X-ray exist (Table 3, entries 2-5).
For example, while the C-11dC-9sN-10sC-5 torsion
(158.14°) is substantially unchanged in 1-I, the other
torsion (-168.36°) and the distance of N-10 from the
C-1, C-5, and C-9 plane (0.139 Å) differ slightly from
the values found by X-ray analysis (Table 3, entry 1).
In the same way, in the high-energy conformers 1-II-
IV (entries 3-5) either a torsion or the N-10 distance
from the plane differ from the corresponding X-ray
values. Therefore, on this basis, the extent of the O-3
to C-11 conjugation through the A, B and C rings in
the predicted conformations of 1 seems to be underes-
timated with respect to 1-X-ray, which instead, espe-
cially in the 4-en-3-one moiety, appears more planar.
Thus, in order to evaluate the contribution to the energy
of the O-3dC-3sC-4dC-5 torsion angle deviation in 1-I
from the value observed in the X-ray structure (-177.8°),
we minimized in the usual way a conformer derived
from 1-I in which the 4-en-3-one moiety was constrained
at -177.8°. The energy found in such a calculation was
only 0.24 kcal/mol different from that of 1-I, a value
which may be taken, therefore, as a measure of the
uncertainty on the energy of the conformer 4-I calcu-
lated by AM1 with respect to the X-ray structure. This
difference could be related either to packing forces in
the crystal of 1, which constrain the A ring to a greater
planarity than in the vacuum, or to the type of calcula-
tion performed, which makes lower account of the
orbital conjugation with respect to other parameters.
In this case, similarly to the calculation carried out on
1-I, if in conformers 1-II-IV the O-3dC-3sC-4dC-5
torsion angle is constrained to planarity, the energy
differences with the unconstrained conformers are only
in the 0.3-0.5 kcal/mol range and, therefore, the rela-
tive energies of conformers 1-I-IV are only slightly
affected.
The conformational analysis of compound 1 requires
at this point the evaluation of the flexibility, i.e. the
energy determination of the transitional barriers be-
tween the predicted conformers I-IV. This is of crucial
importance because, if the barriers are low, during
molecular recognition a molecule could be converted,
with a low energy cost, to a preferred geometry in the
binding site within the enzyme.
The determination of transitional barriers was carried
out through a torsion space exploration in MacroModel,
optimizing the geometry of each conformation obtained
with a combination of sequential rotations in 5° incre-
ments from -80° to 80° of both torsion angles N-10sC-
1sC-2sC-3 (…1) and C-5sC-6sC-7sC-8 (…2). The 2D
conformational MM2* energy map thus obtained for
compound 1 is reported in Figure 7 (top). Six distinct
local minima (I-VI, Figure 7, top) have been found,
corresponding to the conformers already obtained by the
Monte Carlo conformational search. Therefore, the
Monte Carlo random approach and the determination
of the conformational energy map in terms of …1 and
…2 gave the same six conformers. The 2D energy map
is approximately centrosymmetric, with the lowest
interconversion barrier values (in the 2.76-5.68 kcal/
mol range) found for the conformational changes involv-
ing only one of the two torsions. These are the transi-
tions I T II and III T IV (…1 torsion involved) and I T
III and II T IV (…2 torsion involved), and the points A,
C, B, and D represent the barriers to these intercon-
versions. On the contrary, the simultaneous rotation
of …1 and …2 torsion angles corresponds to transitions
(I T IV and II T III) involving energy barriers higher
than 6 kcal/mol. As already discussed, after AM1
geometry optimization, only four conformers have been
found for compound 1, having two couples of MM2*
minima converged to two single conformers (II and V
to 1-II, and I and VI to 1-I). Thus, in order to obtain
more consistent transitional barrier values, the energy
of the conformations corresponding to the points A-D
was refined by rotating the same torsion angles …1 and
…2 in 1° increments in a narrower range (-10  10°)
and optimizing the geometry of the resulting structures
by AM1. This process provided the final AM1 energy
values (Figure 7, bottom) which, of course, might be
affected by the same degree of uncertainty found for the
energy of the predicted conformers.
This analysis clearly suggests that compound 1 is a
flexible molecule, the highest value of transitional
energy being only 3.88 kcal/mol. Therefore, compound
1 should be better described by a fast equilibrium
between conformers 1-I-IV, even though, on the basis
of their relative energies, the global minimum 1-I should
be the prevailing conformation.
Figure 7. MM2* conformational potential energy map of 19-
nor-10-azasteroid 1 (top) and AM1 energy profile of the
barriers between the conformers 1-I-IV (bottom). In the 2D
map (top), the individual conformers are identified by boldface
romanic numbers, the contour level is 2 kJ/mol, and …1 and
…2 correspond to the dihedral angles N-10sC-1sC-2sC-3 and
C-5sC-6sC-7sC-8, respectively; in the energy profile (bottom)
points A, B, C, and D correspond to the barriers between
conformers 1-I-IV and energy values are given in kcal/mol.
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Experimental support to this supposition was found
by recording the 1H NMR spectrum of 1 in CDCl3 and
measuring the four vicinal coupling constants between
the protons on C-1 and C-2 (Table 4, entry 1). The same
constants were measured for the X-ray structure and
for each predicted AM1 conformer of 1 in MacroModel21
and calculated on the basis of the relative population
of the conformers at room temperature (Table 4, entries
2-4). Even though the conformational analysis of 1was
performed in the vacuum, the conformational property
should not be drastically different from that in CDCl3
solution. Thus, comparison of the vicinal constants can
be done. The 3J calculated for 1-X-ray and 1-I (which,
as expected, are similar; see entries 2 and 3) are quite
different from the experimental values (entry 1), espe-
cially from those corresponding to the couplings between
H1 and the vicinal H3 and H4 (J1-3 and J1-4). Instead,
a better accord with the observed values (entry 4) can
be obtained if the coupling constants are calculated
considering the different contribution of the three
conformers I-III (on the basis of their Boltzmann
distribution at room temperature), discarding that of
the least probable conformer 1-IV.22
Conformational Analysis of ¢8(9)-19-Nor-10-aza-
steroid 2 and Compound 3. The same conformational
analysis performed on 1 (Monte Carlo search, followed
by AM1 optimization) has been carried out on its ¢8(9)
regioisomer 2 and on the C-ring-saturated azasteroid
3. Four unique conformations have been found for
compound 2 (entries 6-9, Table 1). Conformers 2-I-
IV have much closer energies than the four minima of
1, included in the narrow range of 0.1 kcal/mol. The
first two conformations (2-I and 2-II) have inverted 1â-
2R A ring type and differ by the B ring type (7â- and
7R-sofa). The other two conformers (2-III and 2-IV)
have normal 1R-2â A rings and again different B ring
conformations. Common features of conformers 2-I-
IV are the quasi-trans A/B ring fusion and a deviation
from the planarity of the O-3dC-3sC-4dC-5 torsion
angle in the 7.7-10.5° range. For this reason, conform-
ers 2-IV and 1-I are very close in the plot depicted in
Figure 5.
Concerning the ð-conjugation through the A, B, and
C rings, two conformers (2-I and 2-IV) have the C-8dC-
9sN-10sC-5 torsion angle (Table 3, entries 6 and 9)
very close to 0° and greater distorsions in the C-4dC-
5sN-10sC-9 dihedral angles (14°), while the remain-
ing conformers (2-II and 2-III) show inverted deviations
(entries 7 and 8). These results, and the fact that the
four conformers of 2 have almost the same energy, do
not allow assignment of a prevailing conjugation of N-10
with one of the two C-C double bonds present in the
molecule.
The presence of a further bridgehead sp2 C atom (C-
8) in compound 2 should provide lower torsional barrier
energies than in regioisomer 1.20 In fact, the torsional
barriers for 2-I-IV, calculated as described for com-
pound 1, are all in the 1.31-1.34 kcal/mol range, and
therefore, a fast equilibrium between four equally
probable conformers should be the best description of
compound 2.
With regard to the C-ring-saturated 19-nor-10-aza-
steroid 3, four conformations have been found after the
usual conformational search. The global minimum
energy conformer 3-I (Table 1, entry 10) has a normal
1R-2â A ring type and a 6â-7R B ring type, similar to
1-I. The C-2 distance from the C-3, C-4, C-5, and N-10
plane is 0.28 Å, thus very close to the same distance in
1-I (0.33 Å). As already observed for 1 and 2, in this
case the modeling also gives absolute values for the
O-3dC-3sC-4dC-5 torsion angle around 170°, and
therefore the lowest energy conformers of 1 and 3 are
very close in the plot of Figure 5. The second conformer
(3-II, entry 11) is 0.81 kcal/mol higher in energy and
has inverted A ring type, and conformer III (entry 12)
also has an inverted A ring type and 7â-sofa B ring,
whereas conformer IV (entry 13) has a normal A ring
type and 7â-sofa B ring. Concerning the determination
of the transitional barriers energy map for azasteroid
3, we should expect that this compound, lacking in the
C-19 angular methyl group and, moreover, with a
bridgehead N atom instead of a sp3 C atom, is a
molecule at least as flexible as 19-nortestosterone.9 In
fact, the barrier values found are 1.83 (3-I T 3-II), 3.78
(3-II T 3-III), 2.32 (3-III T 3-IV), and 3.92 kcal/mol
(3-I T 3-IV), making 3, similar to azasteroids 1 and 2,
a flexible molecule.
Conformational Analysis of Compounds 4-6.
Besides the calculations performed on novel compounds
1-3, we decided to extend our approach to other
steroids, in particular testosterone (4), taken as a
reference structure for the comparative analysis, and
two competitive azasteroidal inhibitors 5 and 6 (Figure
1), in order to gain new insights into the conformational
features of these molecules.
It has already been shown that testosterone is a quite
flexible molecule.9 It displays different conformations
in independent crystals, depending on the presence of
cocrystallized solvent molecules or intermolecular H-
bonds, all having 1R-2â A ring type and a quasi-trans
A/B ring fusion.9 Bucourt et al. found that testosterone
may exist in another form, having an energy 2.7 kcal/
mol higher than the form having a conformation corre-
sponding to the X-ray crystal structure. This second
conformer has inverted 1â-2R A ring type and a quasi-
cis A/B ring fusion.9
Starting from the orthorhombic P212121 crystallo-
graphic structure of testosterone,11 our conformational
analysis provided three unique conformers (Table 2,
entries 2-4). Among these, the global minimum energy
conformation 4-I closely reproduces the X-ray structure
(4-X-ray), the rms fitting being 0.098 Å, whereas 4-II
corresponds to the second conformation (relative energy
2.37 kcal/mol) found by Bucourt.9 Conformer 4-I has
Table 4. Vicinal Coupling Constants for Compound 1
entry J1-3 J1-4 J2-3 J2-4
Observed (Hz)a
1 1 7.2 4.0 12.9 5.3
Calculated (Hz)b
2 1-X-ray 4.9 1.5 12.5 4.3
3 1-I 6.3 0.9 11.8 5.6
4 (1-I + 1-II + 1-III)c 6.4 2.6 10.9 5.8
a 1H NMR (200 MHz) spectrum recorded in CDCl3 at 25 °C.
b Vicinal coupling constants calculated for all conformers by the
NMR option in MacroModel. c Calculated on the basis of the
Boltzmann distribution of these conformers at 25 °C.
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normal 1R-2â A ring type with distances of C-1 and
C-2 from the C-3, C-4, C-5, and C-10 plane very close
to those of 4-X-ray (-0.49 and 0.16 Å in 4-X-ray and
-0.42 and 0.24 Å in 4-I). Conformer 4-II has 1â-2R A
ring type and a quasi-cis A/B ring fusion, as was found
by Bucourt, and the rms fitting with 4-X-ray is 0.384
Å. The third conformer found by us (4-III, relative
energy 3.44 kcal/mol) has a distorted 1R-2R A ring type
and a 6R-7â B ring type, inverted with respect to that
of the global minimum (entry 4) and a quasi-trans A/B
ring fusion. The O-3dC-3sC-4dC-5 dihedral angle in
the predicted conformers 4-I-III undergoes to some
extent a deviation from the planarity, as observed for
all predicted conformers of compounds 1-3. In 4-X-ray
the value of this angle is -179.29°, whereas in 4-I it is
172.38°. This result is consistent with that obtained for
azasteroid 1, and similar reasons can be invoked to
explain the difference in the torsion angle value between
the minimized and the crystallographic structure of
testosterone. However, the difference in the energy due
to this distorsion, determined as done in the case of 1-I,
is only 0.1 kcal/mol. Similarly, in conformer 4-II of
testosterone the uncertainty on the energy due to the
deviation from planarity of the enone moiety was found
to be 0.34 kcal/mol.
The four crystal structures reported for testosterone9
were determined in different crystalline environments
and two are in crystals incorporating solvent. Following
a referee’s suggestion, it might be more appropriate, for
the comparison with the minimized 4-I conformation,
to average the four X-ray structures of testosterone,
since such an average should minimize any specific
intramolecular interactions present in any of the crys-
tals. In Table 5 some selected torsion angle values of
4-I and the corresponding averaged values of the four
crystal structures are reported. Once again, it is evident
how the modeling well reproduces the X-ray structures,
with very small differences between calculated and
averaged values. Moreover, the differences between the
calculated and averaged C-3sC-4dC-5sC-10 and O-3dC-
3sC-4dC-5 dihedral angles (3.0° and 5.5°, respectively)
are even lower than those obtained considering only the
comparison between 4-I and 4-X-ray (Table 2, entries 1
and 2, and Figure 6). The most striking difference
reported in Table 5 concerns the C-10sC-5sC-6sC-7
torsion angle (7.9°), and this deviation may generate
some uncertainty in assigning the B ring conformation
in 4-I. In fact, the C-6 distance found in 4-I (0.09 Å,
Table 2, entry 2) would lead to define the B ring type
as 7R-sofa, but likely, this therminology is inappropri-
ate and the 6â-7R conformation should be correct.
Bucourt suggested that testosterone might be a flex-
ible molecule and, in particular, that the A ring flex-
ibility is only slightly lowered if the position 10 is
occupied by a methyl group or a hydrogen atom as in
19-nortestosterone.9 A complete search of the confor-
mational space of testosterone performed by us with the
procedure above described for 1 gave quite low energy
values for the transitional barriers, that is, 4.62 (4-I T
4-II), 4.75 (4-I T 4-III), and 10.31 kcal/mol (4-II T 4-III,
this transition involving both the torsions). As expected,
transitional barriers of azasteroids 1-3 are lower than
those of testosterone, confirming that the bridgehead
N-10 atom and the further double bond on the C ring
enhance the conformational flexibility.
Also for testosterone, the barrier values might be
affected by a possible error due to the uncertainty on
the energy of 4-I-III (related to the deviation from
planarity of the 4-en-3-one moiety). This in any case
should not alter the barriers to such an extent to prevent
the conformational interconversion between the con-
formers (barriers higher than 20 kcal/mol are usually
required). Therefore, in considering the biological activ-
ity of testosterone, the relative populations of the two
conformers, where the global minimum 4-I predomi-
nates, should be taken into account, probably, more than
the lack of an equilibrium between them.
6-Azasteroidal inhibitor 5 (Figure 1) was synthesized
by Glaxo,6 and like compounds 1-4, it has a 4-en-3-one
moiety. Our molecular modeling approach furnished
only two conformations after AM1 optimization, 5-I and
5-II (see the Experimental Section for the treatment of
the 17â side chain), the latter having an energy 5.31
kcal/mol higher than the global minimum conformer
(Table 2, entries 5 and 6). As evident from the data
reported in Table 2 (entry 5) and from the dihedral angle
values in Figure 6, 5-I resembles the X-ray structure of
testosterone (4-X-ray): the A/B ring fusion is quasi-
trans and a 6â-7R B ring type is present. The A ring
has the normal 1R-sofa conformation,23 but the dis-
tances of C-1 (-0.61 Å) and C-2 (0.02 Å) from the C-3,
C-4, C-5, and C-10 plane are quite close to those of 4-X-
ray (-0.49 Å and 0.16 Å, respectively). More important
is the very low deviation from the planarity of the
O-3dC-3sC-4dC-5 dihedral angle, which is now very
close to 180°. Thus, in the plot depicted in Figure 5,
conformer 5-I and 4-X-ray are very close. The highest
energy conformer 5-II has instead an inverted 2R-sofa
A ring type and a 7R-sofa B ring type (Table 2, entry
6) and shows a considerable distorsion of the 4-en-3-
one moiety (the corresponding angle being -159.37°).
Recently, the X-ray structure of the 17â-[N-[1-(4-
chlorophenyl)cyclopentyl]carbamoyl]-4-chloro-6-azaan-
drost-4-en-3-one has been determined.23 Despite the
presence of the bulky substituent at position 17 and the
Cl atom on the A ring, which in particular could affect
the electronic properties of the enaminone moiety, a
comparison of its steroidal skeleton with that of 5-I is
Table 5. Comparison of Values of Some Selected Torsion
Angles of 4-I with the Corresponding Averaged Values of Four
X-ray Structures of Testosterone
X-ray observationsa
range
(deg)
average
(deg)
4-I
(deg)
diff
(deg)
A Ring
C-10sC-1sC-2sC-3 -53.5  57.5 -55.8 -55.8 0.0
C-1sC-2sC-3sC-4 29.2  37.6 32.8 36.9 4.1
C-2sC-3sC-4dC-5 0.0  -8.1 -3.7 -9.2 5.5
C-3sC-4dC-5sC-10 -1.8  -7.1 -4.3 -1.3 3.0
C-4dC-5sC-10sC-1 -14.7  -19.6 -17.2 -16.2 1.0
C-2sC-1sC-10sC-5 44.8  47.8 46.4 44.5 1.9
B Ring
C-10sC-5sC-6sC-7 -48.1  -51.9 -50.3 -58.2 7.9
C-5sC-6sC-7sC-8 53.1  54.4 53.7 53.8 0.1
C-6sC-7sC-8sC-9 -56.5  -58.7 -57.2 -58.4 1.2
C-7sC-8sC-9sC-10 54.5  58.9 56.9 58.3 1.4
C-8sC-9sC-10sC-5 -46.8  -52.9 -50.0 -51.4 1.4
C-6sC-5sC-10sC-9 44.9  50.2 47.2 48.1 1.1
Other Torsions
O-3dC-3sC-4dC-5 -179.3  179.1 177.8 172.4 5.5
a Taken from ref 9.
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possible. In fact, the two backbones are well superpos-
able, with a small rms fitting value (0.195 Å). In the
X-ray structure, the O-3dC-3sC-4dC-5 torsion angle
is very close (-178.2°) to that found in 5-I and the A
ring conformation is 1R-2R, with distances of C-1 and
C-2 from the C-3, C-4, C-5, and C-10 plane (-0.64 and
-0.15 Å, respectively) well reproduced on the steroidal
skeleton of 5-I (-0.61 and 0.02 Å, Table 2, entry 5). The
B ring has a 6â-7R conformation, as found for 5-I, with
N-6 and C-7 distances values of 0.10 and -0.30 Å,
respectively. On the whole, the modeling of compound
5 has generated a global minimum conformer whose
steroidal skeleton is close to that of the X-ray structure
(Figure 8). Interestingly, the C-2 atom lies preferen-
tially in the plane defined by the C-3, C-4, C-5, and C-10
atoms, and as a consequence, the A ring conformation
in 6-azasteroids seems to be 1R-sofa (or 1R-2R, but
close to the 1R-sofa type).
The internal dihedral angles of the B ring in 5-I and
5-II are very close. For example, the torsion usually
involved in the barrier energy determination, i.e. C-5sN-
6sC-7sC-8, is 40.1° in 5-I (Figure 6) and 46.5° in 5-II.
On the contrary, the dihedral angles change drastically
in the A ring where, for example, the C-2sC-3sC-4dC-5
torsion is -0.6° in 5-I (Figure 6) and 24.6° in 5-II.
Therefore, two torsions of the A ring have been chosen
for the determination of the energy barrier between the
two conformers (C-10sC-1sC-2sC-3 and C-2sC-3sC-
4dC-5) which was, after the usual procedure, 7.40 kcal/
mol. On the basis of this value, the two conformations
of 5 are in equilibrium at room temperature; however,
owing to the great difference between their energies,
6-azasteroid 5 is practically represented only by the
lowest energy conformer 5-I.
All steroids and azasteroids considered so far have a
4-en-3-one moiety in their A ring, and apart from
testosterone, which is a substrate for the enzyme, all
the other compounds, according to the transition state
analogue theory for the enzyme inhibition, may be
thought of as “substrate-like” inhibitors.1 4-Azasteroid
6, developed by Merck,7 has instead a sp3 C atom at
the position 5, thus making it a “product-like” transition
state analogue.1 After the usual Monte Carlo search
and AM1 optimization, two conformers within 1 kcal/
mol are obtained (6-I,II, Table 2, entries 7 and 8) having
both a trans A/B ring fusion. Due to the presence of
the bridgehead sp3 C-5 atom, the extension of the
comparative analysis performed so far to this compound
cannot be done, unless other parameters, different from
the distances of C-1 and C-2 from the C-3, N-4, C-5, and
C-10 plane, are considered. This is evident from Figure
5. Measuring the distances of C-1 and C-2 from the
above mentioned plane, an unusual 1R-2R A ring type
is obtained for 6-I, with values of -0.77 and -0.36 Å,
respectively. Similarly, the second conformer (6-II) has
1R-2R A ring type with a great distance between C-2
and the plane (-1.05 Å).
For 4-azasteroid 6, the differences between the two
predicted conformers 6-I and 6-II are principally due
to conformational changes in the A ring and not to
distorsions of the B ring, whose internal dihedral angles
are almost identical in 6-I and 6-II. For this reason,
similar to compound 5, the 2D conformational energy
map has been determined using two torsion angles of
the A ring (C-10sC-1sC-2sC-3 and C-2sC-3sN-4sC-
5), and the resulting barrier between the two conformers
was only 1.67 kcal/mol.
On the basis of the results obtained in the determi-
nation of the transitional barriers, we may conclude that
4-azasteroids 6 and 6-azasteroid 5 are flexible molecules
only in the A ring, and that they should be considered,
on the whole, more rigid structures than 10-azasteroids
1-3.
From the analysis performed so far on 19-nor-10-
azasteroids 1-3, we have presented evidence that these
compounds are very flexible molecules having transi-
tional barriers lower than 4 kcal/mol. For 1 and 3 the
global minimum energy conformations are predominant,
whereas the four conformations 2-I-IV are almost
equally probable.
The flexibility of an inhibitor can be an advantage
when the molecule in its lowest energy conformation
does not have the right shape for the binding site within
an enzyme, because only a little energy is required for
a particular conformational change. However, in order
to design more rigid analogues, it would be important
to find, among all the thermally accessible conforma-
tions, the bioactive one, i.e. the most suitable for the
fitting with the enzyme cavity. If we take in a simplified
approach the global minimum energy conformer of
testosterone (4-I) as the active conformation of this
substrate, we can analyze all conformers of 10-azaster-
oids 1-3 by comparison with that structure.
Thus, all predicted conformers 1-I-IV, 2-I-IV, and
3-I-IV were superimposed with the lowest energy
conformation found for testosterone (4-I) and the rms
fittings were measured. In this superimposition, all C
(and N) atoms of the skeleton and the C-18 methyl
group were considered, whereas the C-19 methyl group
and the C-17 substituent were disregarded. The reason
for the choice of 4-I and not of 4-X-ray as a reference
structure lies in the fact that both the lowest energy
conformers of 1 and 4 (1-I and 4-I) have parallel
conformational modifications if compared to the corre-
sponding X-ray structures (as evident from Figure 5).
Our modeling also has a constant effect on the O-3dC-
3sC-4dC-5 dihedral angles, and this suggests that it
is more appropriate to compare among minimized
structures than among minimized and X-ray structures.
As a second parameter of analysis we chose the
distance of the O-3 atom in the superimposed structures
from the corresponding atom in 4-I. In fact, we found
that this distance is related to the distortion of the A
and B rings with respect to testosterone 4-I and it can
be plotted versus the rms (Figure 9). This helped us to
identify the most similar conformations to 4-I. Indeed,
these conformations could be found by the A and B ring
type analysis. For example, in Figure 5, two conformers
Figure 8. Steroidal backbone superposition of conformer 5-I
and the X-ray structure of 17â-[N-[1-(4-chlorophenyl)cyclo-
pentyl]carbamoyl]-4-chloro-6-azaandrost-4-en-3-one.23
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of both 1 and 2 are very close to 4-I (1-I and 1-III, and
2-III and 2-IV), each of them having 1R-2â A ring type
as in 4-I and differing by the R or â C-7 atom in the B
ring. One should expect that the two conformers of 1
and 2 having also a B ring type similar to that of
testosterone would be the most similar structures to 4-I.
This actually occurs; in fact, superimposing all predicted
conformers of 1, 2, and 3 and plotting as described above
(Figure 9) yields only three structures that are close to
the lowest energy conformer of 4, and they are the global
minima 1-I (distance 0.815 Å and rms 0.315 Å) and 3-I
(distance 0.599 Å, rms 0.178 Å) and the conformer 2-IV
(distance 0.782 Å, rms 0.324 Å), all having 1R-2â A ring
type and a 7R carbon atom in the B ring (Figure 10).
Conformer 3-I is the closest conformer to 4-I, and this
results also from the comparison of the dihedral angles
reported in Figure 6. In fact, excluding those of the D
ring, all the other torsions are very similar, although
the N-10 atom, conjugated with the 4-en-3-one moiety,
causes a decrease of the C-6sC-5sN-10sC-9 torsion
angle value in 3-I (32.5° compared to 48.1° in 4-I). All
the others conformers (Figure 9) have both higher rms
(>0.4 Å) and distance (>1 Å), with the A ring distorsion
(with respect to 4-I) contributing to the deviation from
the reference structure to a greater extent than the
differences in the B ring type. Thus, if with a and A
we indicate the normal and inverted A ring types,
respectively, and with b and B the normal and inverted
B ring types (referring to testosterone), the sequence
ab < aB < Ab < AB defines the relative degree of
conformational distorsion for the 19-nor-10-azasteroids.
This type of analysis is more complete with respect to
a simple rms best fit, since it is very useful to bring into
consideration the differences between conformers of the
same compound. In fact, two or more conformers of an
azasteroid, despite having very similar rms fitting
values with 4-I, can occupy distant relative positions
in the plot of Figure 9. This can be due to a considerable
difference between the distortions of both the A and B
rings in the examined conformers not suggested by the
analysis of the rms values.
Since 19-nor-10-azasteroids 1-3 are competitive in-
hibitors of 5RR and testosterone (4) its natural sub-
strate, the analysis above performed suggests that 1-I,
2-IV, and 3-I, the closest conformers to testosterone,
could also reasonably be considered the active confor-
mations of compounds 1-3. We have already shown
that the 17â-N-tert-butylcarbamoyl substituent consid-
erably enhances the inhibitory potency of these com-
pounds.1 This effect should be related to the interaction
of this substituent with the enzyme active site rather
than to conformational changes induced by the C-17
substituent. In fact we have observed that the differ-
ence in the C-17 hybridization in 19-nor-10-azasteroids
has no significant effect on the number (apart from the
rotamers due to the presence of a 17â substituent) or
type of conformation and skeleton flexibility, which are
instead determined by the particular features of the A
and B rings.24 Therefore, the conformers having the
1R-2â A ring type and a 6â-7R or 7R-sofa B ring type
can be thought as the bioactive conformations of the 19-
nor-10-azasteroid inhibitors.
Finally, applying the same analysis to the other 4-en-
3-one azasteroidal inhibitor, i.e. 6-azasteroid 5, resulted
in that the lowest energy conformer 5-I is very close to
4-I, having small values of rms (0.104 Å) and distance
(0.502 Å). Thus, on the basis of the same considerations
done for 19-nor-10-azasteroids, 5-I could be considered
the bioactive conformer for this azasteroid.
Conclusion
Several classes of steroidal and nonsteroidal inhibi-
tors have been synthesized and tested toward 5RR-1 and
5RR-2. However, to our knowledge, few molecular
modeling studies on such inhibitors have been reported,
and they mainly examine the conformation of the 17â
substituent.23,25,26
The X-ray structure of steroids is very close in many
cases to the global minimum energy conformer.15-17
When the X-ray structure of a steroidal compound is
not available, as in the case of most of azasteroids,
calculation may be a useful tool to obtain reliable
informations about the conformational features of the
molecule, especially if the modeling has been “tested”
by reproducing the crystallographic structure of struc-
turally similar compounds and evaluating the possible
inaccuracies on particular torsion angles or bond dis-
tances.
19-Nor-10-azasteroids are a new class of inhibitors
whose activity is dependent on the presence of the
bridgehead N-10 atom conjugated with the 4-en-3-one
moiety in the A ring.
In the present work, we have performed a molecular
modeling study focused on the conformational effects
on the steroidal skeleton of modifications to the A, B or
C rings, considering in particular three classes of
azasteroids in comparison with testosterone.
A complete conformational analysis of these com-
pounds has been performed to determine the number
and energy of the possible conformers as well as the
molecular flexibility of the 10-azasteroidal skeleton. The
same analysis has been then extended to testosterone
Figure 9. Superposition of conformers I-IV of compounds 1
(0), 2 (O), and 3 (*) with 4-I. The O-3 distance of each
superimposed conformer from the corresponding atom in 4-I
is plotted versus the rms fitting value.
Figure 10. Stereoplot of superposition of conformers 1-I, 2-IV,
and 3-I with 4-I.
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(4) and to the 6- and 4-azasteroid inhibitors 5 and 6,
respectively. The most important features we have
pointed out are as follows:
19-Nor-10-azasteroids 1-3, as well as testosterone (4),
having low transitional barrier energy values, are
flexible molecules.
Four conformations describe azasteroids 1-3, while
three conformers are found for testosterone; considering
their relative energies, the global minimum energy
conformations of 1, 3, and 4 are predominant, whereas
for azasteroid 2 the four conformations are equally
probable.
For compounds 1 and 4, the conformational analysis
indicated that the lowest energy conformers 1-I and 4-I
well reproduce the corresponding crystallographic struc-
tures, although these, concerning the conjugated system
in the A rings, appear more planar.
Only two conformations describe 6-azasteroid 5 and
4-azasteroid 6, which, moreover, are more rigid mol-
ecules than 19-nor-10-azasteroids.
From a best fit analysis of all predicted conformers
of 1-3 with the global minimum of testosterone (4-I),
taken as the active conformation of testosterone, we
have found that the conformers 1-I, 3-I, and 2-IV,
having 1R-2â A ring type and a C-7 atom in the position
R, are the closest structures to 4-I. Thus, 1-I, 2-IV, and
3-I could reasonably be thought of as the bioactive
conformations of these compounds. Moreover, the con-
formational properties of the 19-nor-10-azasteroid skel-
eton being unaffected by the substituent at position 17,
the 1R-2â A ring type and the 6â-7R or 7R-sofa B ring
types should be the determining conformational features
of the bioactive conformers of this class of azasteroid.
This best fit analysis cannot be considered conclusive
in explaining the changes in the inhibitory potency
determined by the presence and position of the double
bond in the C ring of 19-nor-10-azasteroids. Instead it
is very useful in identifying the possible active confor-
mation for a particular inhibitor. However, another
important finding of this paper is the low number of
thermally accessible conformations of 4- and 6-azaste-
roidal compounds. For this reason, these two classes
of inhibitors could be used to develop models of the
enzyme active site. Recently, we have proposed a model
cavity for 5RR-2 conceived following the “active analogue
approach” and based on the 4-azasteroid inhibitors.27
Similarly, a new model based on the 6-azasteroid
inhibitors as mimics of a “substrate-like” transition
state1,4,27 could be now envisaged. In this context, the
present results of conformational analysis and deter-
mination of the molecular flexibility of 19-nor-10-
azasteroids (which can be considered “substrate-like”
transition state analogues) should allow the application
of such a model with the final goal of explaining the
difference in inhibitory activity observed for the ¢8(9),
¢9(11), and C-ring-saturated isomers of 19-nor-10-aza-
steroids.
Experimental Section
Steroids. 19-Nor-10-azasteroids 1-3 were synthesized as
previously described.1 A 10:1 mixture of 19-nor-10-azaan-
drosta-4,9(11)-diene-3,17-dione [or 10-azaestra-4,9(11)-diene-
3,17-dione] (1) and 19-nor-10-azaandrosta-4,8(9)-diene-3,17-
dione [or 10-azaestra-4,8(9)-diene-3,17-dione] (2) was crystallized
twice from ethyl acetate in order to remove the minor isomer,
and suitable crystals for X-ray analysis were obtained by slow
concentration of an ethyl acetate solution of pure compound
1.
X-ray Crystallography of 1. Investigation on a single
crystal of 1 of approximate dimensions of 0.15  0.30  0.45
mm was carried out with an Enraf-Nonius CAD4 X-ray
diffractometer by using a ı-2ı scan. During data collection
three reflections were monitored periodically to check the
stability of the diffractometer and the crystal. Intensity data
were corrected for Lorentz and polarization effects and an
absorption correction was applied when the structure was
solved by using the Walker and Stuart method.28 The struc-
ture was solved by direct methods of SIR9229 and subsequently
refined by a full-matrix least square technique on F2 of
SHELXL-93.30 Atomic scattering factors were taken from the
literature.31 All the non-hydrogen atoms were treated aniso-
tropically, while the hydrogen ones were introduced in calcu-
lated positions and refined according to the linked atoms with
an overall temperature factor refined to 0.0735 Å2. The
assignment of the absolute configuration was not possible on
the basis of the X-ray data, thus the correct enantiomer was
set from chemical evidences.
Crystal data were as follows: C17H21NO2,Mr ) 271.35, a )
9.829(9) Å, b ) 10.380(3) Å, c ) 13.988(5) Å, V ) 1427(2) Å3,
space group ) P212121, orthorhombic, Dx ) 1.263 g cm-3, ì(Mo
KR) ) 0.71069 Å, T ) 298 K. A total of 1430 reflections were
collected (5° < 2ı < 50°). The refinement of the structure used
1419 observed reflections [I > 2ó(I)]. Refined parameters were
183. Final R indices were R1 ) 0.0453 and wR2 ) 0.1215. ¢F
in the final difference map was within 0.126 and -0.143 e Å-3.
Molecular Modeling. The crystal structure of 19-nor-10-
azasteroid 1 was used as input for computer modelization of
19-nor-10-azasteroids 1-3 and that of testosterone (T)11 for
the modeling of 4-6.
All models and X-ray structures were displayed on a IBM/
RISC 6000 workstation by the MacroModel (version 4.5)32
molecular modeling software which was also used for the
molecular mechanics calculations (MM2* forcefield). Semiem-
pirical (AM1) calculations were carried out through Spartan
3.1.33 All the described molecular modeling calculations used
default values of the specific software unless otherwise indi-
cated. A conformational analysis of the substituent at the
position 17 of testosterone (4), 6-azasteroid 5, and 4-azasteroid
6 was carried out. The lowest energy conformation obtained
for the C-17 substituent was thus maintained constant during
all conformational searchs soon after performed. Conforma-
tional analyses were carried out by the Monte Carlo method
in MacroModel, and conformational energy surface data of
azasteroids and testosterone were generated from torsional
space determination using the “Dihedral Driver” option of
MacroModel, as described in the Results and Discussion
section.
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